Skip to content

Risk Evaluation and Management in Heart Failure

Risk Evaluation and Management in Heart Failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02998788
Acronym
REM-HF
Enrollment
1000
Registered
2016-12-20
Start date
2016-06-30
Completion date
2026-12-31
Last updated
2016-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Risk Factor, Cardiovascular

Keywords

heart failure, risk factor, cardiovascular disease, lifestyle behavior

Brief summary

This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.

Detailed description

Heart failure is the main cause of cardiovascular death. The primary goal of this study is to estimate the association of lifestyle behavior (e.g., alcohol, tea and coffee consumption, sedentary behavior, smoking habit, sleep disorder and physical activity), intermediate conditions (e.g., hypertension, diabetes and dyslipidemia), genetic risk factors and circulating biomarkers with heart failure prognosis. Another goal is to improve the health status and reduce cardiovascular events and death for heart failure patients via patient education, disease monitoring and medication titration. This study planned to consecutively enroll 1,000 heart failure patients fulfilling the inclusion criteria. Each participants will be followed up for at least 5 years. The study endpoints, all-cause mortality and cardiovascular events, will be identified by directly contacting participants during the follow-up surveys, checking pertinent medical records and discharge lists from the hospitals, or checking death certificates from local vital statistics offices. The Cox proportional hazard model will be used to estimate the risk factors for health outcomes in heart failure patients.

Interventions

None listed

Sponsors

Ruijin Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* aged 18 and above * inpatient with one of the following clinical situations: * congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema) * cardiogenic shock * Insufficient high output cardiac * with impaired cardiac function diagnosed by echocardiography * able to provide informed consent

Exclusion criteria

* expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortality10 years
A composite of cardiovascular events10 yearsA composite of myocardial infarction, revascularization, stroke, rehospitalization due to heart failure and cardiovascular death

Secondary

MeasureTime frame
stroke10 years
myocardial infarction10 years
cardiovascular death10 years
rehospitalization due to heart failure10 years
revascularization10 years

Countries

China

Contacts

Primary ContactZhijun Wu, MD
totito19822005@126.com008613818908053

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026